Pith. sign in

REVIEW

GSVMA: A Genetic-Support Vector Machine-Anova method for CAD diagnosis based on Z-Alizadeh Sani dataset

Not yet reviewed by Pith; the record is open.

This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.

SPECIMEN: schema-true, not a live event

T0 review · schema-true

One-sentence machine reading of the paper's core claim.

pith:XXXXXXXX · record.json · timestamp

arxiv 2108.08292 v1 pith:EYQ4YVRV submitted 2021-07-23 cs.LG

classification cs.LG
keywords datasetdiagnosisgsvmamethodgeneticmachinesaniz-alizadeh
verification ladder T0 review T1 audit T2 compute T3 formal

Signed reviews

No signed human review yet.

0 comments
read the original abstract

Coronary heart disease (CAD) is one of the crucial reasons for cardiovascular mortality in middle-aged people worldwide. The most typical tool is angiography for diagnosing CAD. The challenges of CAD diagnosis using angiography are costly and have side effects. One of the alternative solutions is the use of machine learning-based patterns for CAD diagnosis. Hence, this paper provides a new hybrid machine learning model called Genetic Support Vector Machine and Analysis of Variance (GSVMA). The ANOVA is known as the kernel function for SVM. The proposed model is performed based on the Z-Alizadeh Sani dataset. A genetic optimization algorithm is used to select crucial features. In addition, SVM with Anova, Linear SVM, and LibSVM with radial basis function methods were applied to classify the dataset. As a result, the GSVMA hybrid method performs better than other methods. This proposed method has the highest accuracy of 89.45% through a 10-fold cross-validation technique with 35 selected features on the Z-Alizadeh Sani dataset. Therefore, the genetic optimization algorithm is very effective for improving accuracy. The computer-aided GSVMA method can be helped clinicians with CAD diagnosis.

Discussion (0). Continue with ORCID to comment.

Pith tools